Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls

Psychiatry Res. 2017 Dec:258:9-14. doi: 10.1016/j.psychres.2017.09.071. Epub 2017 Sep 28.

Abstract

Previous studies on the relationship between autoimmune diseases, schizophrenia, and bipolar disorder are mainly based on hospital discharge registers with insufficient coverage of outpatient data. Furthermore, data is scant on the prevalence of autoimmune diseases in bipolar subgroups. Here we estimate the self-reported prevalences of autoimmune diseases in schizophrenia, bipolar disorder type I and II, and controls. Lifetime prevalence of autoimmune diseases was assessed through a structured interview in a sample of 9076 patients (schizophrenia N = 5278, bipolar disorder type I N = 1952, type II N = 1846) and 6485 controls. Comparative analyses were performed using logistic regressions. The prevalence of diabetes type 1 did not differ between groups. Hyperthyroidism, hypothyroidism regardless of lithium effects, rheumatoid arthritis, and polymyalgia rheumatica were most common in bipolar disorder. Systemic lupus erythematosus was less common in bipolar disorder than in the other groups. The rate of autoimmune diseases did not differ significantly between bipolar subgroups. We conclude that prevalences of autoimmune diseases show clear differences between schizophrenia and bipolar disorder, but not between the bipolar subgroups.

Keywords: Bipolar disorder; Epidemiology; Neuroimmunology; Schizophrenia.

MeSH terms

  • Autoimmune Diseases / epidemiology*
  • Bipolar Disorder / epidemiology*
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Schizophrenia / epidemiology*